Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara L Lin

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Oncotargets and Therapy|April 14, 2012
Hedgehog pathway as a drug target: Smoothened inhibitors in developmentTara L Lin, William Matsui
Blood Advances|March 13, 2026
Does age matter? Optimizing AML treatment in older adultsCatherine Lai, Tara L Lin
Expert Review of Hematology|February 17, 2021
The important role of intensive induction chemotherapy in the treatment of acute myeloid leukemiaTara L Lin, Livio Pagano
Current Oncology Reports|May 27, 2004
Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questionsTara L Lin, Julie R Brahmer
Clinical Medicine Insights. Oncology|June 2, 2012
Acute myeloid leukemia: focus on novel therapeutic strategiesTara L Lin, M Yair Levy
Hematology. American Society of Hematology. Education Program|December 9, 2023
The approach of HMA plus VEN with or without BMT for all patients with AMLHeather J Male, Tara L Lin
Personalized Medicine|May 20, 2018
Research Highlights: Highlights from the latest articles in molecular profiling and prognosis in acute myeloid leukemiaOmar S Aljitawi, Tara L Lin
The American Journal of the Medical Sciences|April 28, 2011
Prognostically important molecular markers in cytogenetically normal acute myeloid leukemiaTara L Lin, B Douglas Smith
Pediatric Research|August 23, 2007
Cancer stem cells: the root of the problemTara L Lin, Cecilia Fu, Kathleen M Sakamoto
Leukemia Research|June 6, 2022
Central nervous system involvement in adult acute myeloid leukemia patientsJoshua Tatarian, Kenneth Byrd, Heather J Male, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Oncotargets and Therapy|April 14, 2012
Hedgehog pathway as a drug target: Smoothened inhibitors in developmentTara L Lin, William Matsui
Blood Advances|March 13, 2026
Does age matter? Optimizing AML treatment in older adultsCatherine Lai, Tara L Lin
Expert Review of Hematology|February 17, 2021
The important role of intensive induction chemotherapy in the treatment of acute myeloid leukemiaTara L Lin, Livio Pagano
Current Oncology Reports|May 27, 2004
Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questionsTara L Lin, Julie R Brahmer
Clinical Medicine Insights. Oncology|June 2, 2012
Acute myeloid leukemia: focus on novel therapeutic strategiesTara L Lin, M Yair Levy
Hematology. American Society of Hematology. Education Program|December 9, 2023
The approach of HMA plus VEN with or without BMT for all patients with AMLHeather J Male, Tara L Lin
Personalized Medicine|May 20, 2018
Research Highlights: Highlights from the latest articles in molecular profiling and prognosis in acute myeloid leukemiaOmar S Aljitawi, Tara L Lin
The American Journal of the Medical Sciences|April 28, 2011
Prognostically important molecular markers in cytogenetically normal acute myeloid leukemiaTara L Lin, B Douglas Smith
Pediatric Research|August 23, 2007
Cancer stem cells: the root of the problemTara L Lin, Cecilia Fu, Kathleen M Sakamoto
Leukemia Research|June 6, 2022
Central nervous system involvement in adult acute myeloid leukemia patientsJoshua Tatarian, Kenneth Byrd, Heather J Male, et al.
Pageof 9